Yash Joshi

Title(s)Assistant Professor in Residence, Psychiatry
SchoolVc-health Sciences-schools
Address200 W. Arbor Drive #8218
San Diego CA 92103
Phone000-000-NULL
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Therapeutic Inhibition of Acid Sensing Ion Channel 1a Recovers Heart Function After Ischemia-Reperfusion Injury. Circulation. 2021 Jul 15. Redd MA, Scheuer SE, Saez NJ, Yoshikawa Y, Chiu HS, Gao L, Hicks M, Villanueva JE, Joshi Y, Chow CY, Cuellar-Partida G, Peart JN, See Hoe LE, Chen X, Sun Y, Suen JY, Hatch RJ, Rollo B, Alzubaidi MAH, Maljevic S, Quaife-Ryan GA, Hudson JE, Porrello ER, White MY, Cordwell SJ, Fraser JF, Petrou S, Reichelt ME, Thomas WG, King GF, Macdonald PS, Palpant NJ. PMID: 34264749.
      View in: PubMed   Mentions:    Fields:    
    2. The viability of the frequency following response characteristics for use as biomarkers of cognitive therapeutics in schizophrenia. Schizophr Res. 2021 Jun 26. Clayson PE, Joshi YB, Thomas ML, Tarasenko M, Bismark A, Sprock J, Nungaray J, Cardoso L, Wynn JK, Swerdlow NR, Light GA. PMID: 34187732.
      View in: PubMed   Mentions:    Fields:    
    3. Anticholinergic Medication Burden-Associated Cognitive Impairment in Schizophrenia. Am J Psychiatry. 2021 May 14; appiajp202020081212. Joshi YB, Thomas ML, Braff DL, Green MF, Gur RC, Gur RE, Nuechterlein KH, Stone WS, Greenwood TA, Lazzeroni LC, MacDonald LR, Molina JL, Nungaray JA, Radant AD, Silverman JM, Sprock J, Sugar CA, Tsuang DW, Tsuang MT, Turetsky BI, Swerdlow NR, Light GA. PMID: 33985348.
      View in: PubMed   Mentions:    Fields:    
    4. Abnormal phase discontinuity of alpha- and theta-frequency oscillations in schizophrenia. Schizophr Res. 2021 05; 231:73-81. Koshiyama D, Miyakoshi M, Tanaka-Koshiyama K, Joshi YB, Sprock J, Braff DL, Light GA. PMID: 33780847.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    5. Hierarchical Pathways from Sensory Processing to Cognitive, Clinical, and Functional Impairments in Schizophrenia. Schizophr Bull. 2021 03 16; 47(2):373-385. Koshiyama D, Thomas ML, Miyakoshi M, Joshi YB, Molina JL, Tanaka-Koshiyama K, Sprock J, Braff DL, Swerdlow NR, Light GA. PMID: 32856089.
      View in: PubMed   Mentions: 6     Fields:    
    6. Source decomposition of the frontocentral auditory steady-state gamma band response in schizophrenia patients and healthy subjects. Psychiatry Clin Neurosci. 2021 May; 75(5):172-179. Koshiyama D, Miyakoshi M, Joshi YB, Nakanishi M, Tanaka-Koshiyama K, Sprock J, Light GA. PMID: 33470494.
      View in: PubMed   Mentions:    Fields:    
    7. Unique contributions of sensory discrimination and gamma synchronization deficits to cognitive, clinical, and psychosocial functional impairments in schizophrenia. Schizophr Res. 2021 02; 228:280-287. Koshiyama D, Miyakoshi M, Thomas ML, Joshi YB, Molina JL, Tanaka-Koshiyama K, Sprock J, Braff DL, Swerdlow NR, Light GA. PMID: 33493776.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    8. Sources of the frontocentral mismatch negativity and P3a responses in schizophrenia patients and healthy comparison subjects. Int J Psychophysiol. 2021 Mar; 161:76-85. Koshiyama D, Miyakoshi M, Joshi YB, Nakanishi M, Tanaka-Koshiyama K, Sprock J, Light GA. PMID: 33453303.
      View in: PubMed   Mentions:    Fields:    
    9. Neural network dynamics underlying gamma synchronization deficits in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 2021 Apr 20; 107:110224. Koshiyama D, Miyakoshi M, Joshi YB, Molina JL, Tanaka-Koshiyama K, Joyce Sprock , Braff DL, Swerdlow NR, Light GA. PMID: 33340619.
      View in: PubMed   Mentions:    Fields:    
    10. Neurophysiologic Characterization of Resting State Connectivity Abnormalities in Schizophrenia Patients. Front Psychiatry. 2020; 11:608154. Koshiyama D, Miyakoshi M, Tanaka-Koshiyama K, Joshi YB, Molina JL, Sprock J, Braff DL, Light GA. PMID: 33329160.
      View in: PubMed   Mentions:
    11. Gamma oscillations predict pro-cognitive and clinical response to auditory-based cognitive training in schizophrenia. Transl Psychiatry. 2020 11 23; 10(1):405. Molina JL, Thomas ML, Joshi YB, Hochberger WC, Koshiyama D, Nungaray JA, Cardoso L, Sprock J, Braff DL, Swerdlow NR, Light GA. PMID: 33230190.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    12. Memantine effects on auditory discrimination and training in schizophrenia patients. Neuropsychopharmacology. 2020 12; 45(13):2180-2188. Swerdlow NR, Bhakta SG, Talledo J, Kotz J, Roberts BZ, Clifford RE, Thomas ML, Joshi YB, Molina JL, Light GA. PMID: 32961542.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    13. Abnormal Spontaneous Gamma Power Is Associated With Verbal Learning and Memory Dysfunction in Schizophrenia. Front Psychiatry. 2020; 11:832. Tanaka-Koshiyama K, Koshiyama D, Miyakoshi M, Joshi YB, Molina JL, Sprock J, Braff DL, Light GA. PMID: 33110410.
      View in: PubMed   Mentions:
    14. A distributed frontotemporal network underlies gamma-band synchronization impairments in schizophrenia patients. Neuropsychopharmacology. 2020 12; 45(13):2198-2206. Koshiyama D, Miyakoshi M, Joshi YB, Molina JL, Tanaka-Koshiyama K, Sprock J, Braff DL, Swerdlow NR, Light GA. PMID: 32829382.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    15. Contextualizing the road to recovery: A novel method of assessing outcome trajectories in clinical trials. Psychol Serv. 2020 Jul 13. Treichler EBH, Cardoso L, Du Y, Nungaray J, Hochberger WC, Joshi YB, Sprock J, Cohen AN, Light GA. PMID: 32658511.
      View in: PubMed   Mentions:    Fields:    
    16. Abnormal Effective Connectivity Underlying Auditory Mismatch Negativity Impairments in Schizophrenia. Biol Psychiatry Cogn Neurosci Neuroimaging. 2020 11; 5(11):1028-1039. Koshiyama D, Miyakoshi M, Joshi YB, Molina JL, Tanaka-Koshiyama K, Sprock J, Braff DL, Swerdlow NR, Light GA. PMID: 32830097.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    17. Memantine Effects on Electroencephalographic Measures of Putative Excitatory/Inhibitory Balance in Schizophrenia. Biol Psychiatry Cogn Neurosci Neuroimaging. 2020 06; 5(6):562-568. Molina JL, Voytek B, Thomas ML, Joshi YB, Bhakta SG, Talledo JA, Swerdlow NR, Light GA. PMID: 32340927.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    18. Oscillatory biomarkers of early auditory information processing predict cognitive gains following targeted cognitive training in schizophrenia patients. Schizophr Res. 2020 01; 215:97-104. Hochberger WC, Thomas ML, Joshi YB, Molina J, Treichler EBH, Nungaray J, Cardoso L, Sprock J, Swerdlow N, Light GA. PMID: 31759809.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    19. Verbal learning deficits associated with increased anticholinergic burden are attenuated with targeted cognitive training in treatment refractory schizophrenia patients. Schizophr Res. 2019 06; 208:384-389. Joshi YB, Thomas ML, Hochberger WC, Bismark AW, Treichler EBH, Molina J, Nungaray J, Cardoso L, Sprock J, Swerdlow NR, Light GA. PMID: 30738698.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    20. Divergence of subjective and performance-based cognitive gains following cognitive training in schizophrenia. Schizophr Res. 2019 08; 210:215-220. Treichler EBH, Thomas ML, Bismark AW, Hochberger WC, Tarasenko M, Nungaray J, Cardoso L, Joshi YB, Zhang W, Sprock J, Swerdlow N, Cohen AN, Light GA. PMID: 30660574.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    21. Using EEG-Guided Basket and Umbrella Trials in Psychiatry: A Precision Medicine Approach for Cognitive Impairment in Schizophrenia. Front Psychiatry. 2018; 9:554. Joshi YB, Light GA. PMID: 30510520.
      View in: PubMed   Mentions:
    22. Neurophysiologic measures of target engagement predict response to auditory-based cognitive training in treatment refractory schizophrenia. Neuropsychopharmacology. 2019 02; 44(3):606-612. Hochberger WC, Joshi YB, Thomas ML, Zhang W, Bismark AW, Treichler EBH, Tarasenko M, Nungaray J, Sprock J, Cardoso L, Swerdlow N, Light GA. PMID: 30377381.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    23. Targeted cognitive training improves auditory and verbal outcomes among treatment refractory schizophrenia patients mandated to residential care. Schizophr Res. 2018 12; 202:378-384. Thomas ML, Bismark AW, Joshi YB, Tarasenko M, Treichler EBH, Hochberger WC, Zhang W, Nungaray J, Sprock J, Cardoso L, Tiernan K, Attarha M, Braff DL, Vinogradov S, Swerdlow N, Light GA. PMID: 30055883.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    24. Computerized cognitive training is associated with improved psychosocial treatment engagement in schizophrenia. Schizophr Res. 2018 12; 202:341-346. Thomas ML, Treichler EBH, Bismark A, Shiluk AL, Tarasenko M, Zhang W, Joshi YB, Sprock J, Cardoso L, Tiernan K, Light GA. PMID: 29929773.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    25. Mismatch negativity impairment is associated with deficits in identifying real-world environmental sounds in schizophrenia. Schizophr Res. 2018 01; 191:5-9. Joshi YB, Breitenstein B, Tarasenko M, Thomas ML, Chang WL, Sprock J, Sharp RF, Light GA. PMID: 28927552.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    26. Dissociative Intoxication and Prolonged Withdrawal Associated With Phenibut: A Case Report. J Clin Psychopharmacol. 2017 08; 37(4):478-480. Joshi YB, Friend SF, Jimenez B, Steiger LR. PMID: 28614159.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    27. Single-Dose Memantine Improves Cortical Oscillatory Response Dynamics in Patients with Schizophrenia. Neuropsychopharmacology. 2017 Dec; 42(13):2633-2639. Light GA, Zhang W, Joshi YB, Bhakta S, Talledo JA, Swerdlow NR. PMID: 28425497.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    28. 5-lipoxygenase activating protein reduction ameliorates cognitive deficit, synaptic dysfunction, and neuropathology in a mouse model of Alzheimer's disease. Biol Psychiatry. 2013 Sep 01; 74(5):348-56. Giannopoulos PF, Chu J, Joshi YB, Sperow M, Li JG, Kirby LG, Praticò D. PMID: 23683389.
      View in: PubMed   Mentions: 15     Fields:    Translation:AnimalsCells
    Yash's Networks
    Concepts (80)
    Derived automatically from this person's publications.
    _
    Co-Authors (18)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _